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The growth of beta hemolytic streptococci is accompanied by the elaboration of 
extracellular  products  which  constitute  a  complex mixture of proteins,  many with 
specific biologic, enzymatic, and antigenic properties. The ability to induce lympho- 
cyte blastogenic  transformation  has been  reported  in  several  fractions and  present 
evidence indicates that there are multiple blastogenic activities in these preparations 
(1, 2). Blastogenic activity is produced by a variety of strains of group A streptococci 
(3)  in amounts generally larger than those produced by group C, D, and G  strains. 
Streptococcal blastogenic substances from group A strains which have been partially 
purified  include  a  glyeopeptide which  is  extractable  from cells  (4,  5),  at  least  two 
fractions described by Abe and Alouf (6), and a  heterogeneous group of substances 
from  a  column  separation  by  Seravalli  and  Taranta  (1).  Streptococcal  pyrogenic 
exotoxins A, B, and C  are the only entities with lymphocyte stimulating activity that 
have thus far been obtained in a  homogeneous state (7-9). 
The  blastogenic  response  to  the  group  C  products  present  in  the  commercial 
preparation  streptokinase/streptodornase  varies  among  individuals  and  has  been 
shown to be associated in responders with histocompatibility antigen specificity HLA 
B5 (10). As an initial step toward determining whether the response to a blastogen of 
group A  streptococci is also genetically linked, the present study was undertaken  to 
obtain a blastogen in pure form. This report describes the purification of a blastogen 
of group A streptococci 0alastogen A) and some of its properties. 
Materials and Methods 
Bacterial Strains.  Strain C203S of group A streptococci was used as the principal source of 
extracellular products. This strain was originally obtained from Dr. Alan  Bernheimer, New 
York University, New York. $43 is a prototype M6 strain originally obtained from Dr. Rebecca 
Lancefield, The Rockefeller University, New York. The other strains used in this study were 
from the collection  of this laboratory. 
Streptococcal Pyrogenic Exotoxins.  Purified streptococcal pyrogenic exotoxins  A, B, and C and 
rabbit  antisera  to  those  proteins  were  generously  provided by Dr.  D.  Watson  and  Dr.  P. 
Schlievert,  Department of Microbiology, University of Minnesota, Minneapolis, Minn. 
Growth of Organisms and Preparation of Extracellular Products.  Streptococcal strains were grown 
overnight to stationary phase in 5- to 10-liter batches of Todd-Hewitt dialysate medium. The 
cells  were  harvested  by  centrifugation  and  the  supernate  adjusted  to  85%  saturation  in 
(NH4)2SO4, and  allowed to precipitate overnight  at  4°C.  The precipitate was collected  by 
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centrifugation, dissolved in 0.05 vol of 0.001  M Tris HCI, 0.001  M CaCI2, 0.001  M  MgCI2 (pH 
7.0) and dialyzed overnight against the same buffer. 
Ion Exchange Chromatography.  DEAE-cellulose (Whatman  DE-23;  H.  Reeve Angel & Co., 
Inc., Clifton, N. J.) was equilibrated with the starting buffer (0.001  M Tris HCI [pH 7.0], 0.001 
M  CaCI2,  0.001  M  MgCl2)  and  packed  in  a  45  ×  2.5-cm  column.  The  sample of crude 
extracellular products was applied and the column was washed with 5 vol of starting buffer 
and eluted with a linear gradient of NaCI to 0.5 M. 
CM-cellulose (Whatman CM-52; H. Reeve Angel & Co., Inc.) was equilibrated with 0.01  M 
sodium acetate (pH 5.0) and packed in a 45  X  2.5-cm column. The pooled blastogenic activity 
from the DEAE column fractions, previously dialyzed against the starting buffer, was applied 
and the column eluted with a gradient of NaCI from 0.1 to 0.35 M. 
Nuclease Assay.  Nuclease activity was assayed by the acid-soluble technique as previously 
described (11). 
Polyacrylamide Gel Electrophoresis.  Polyacrylamide gel electrophoresis was carried out essen- 
tially as described by Davis (12) with protein bands visualized with Coomassie Blue G250 (13) 
sodium dodecyl sulfate (SDS) 1 polyacrylamide gel electrophoresis was done by the method of 
Weber and Osborne (14). 
Lymphocyte Blastogenic Transformation Assay.  Blastogenic activity was measured by [3H]thy- 
midine incorporation by a gradient-separated monocyte population from human blood. 
Heparinized whole blood, diluted with an equal volume of Eagles' minimal essential medium 
containing  100  U  of penicillin and  streptomycin and  2  mmol  of L-glutamine/ml  (MEM) 
(Grand Island Biological Co., Grand Island, N. Y.) was layered on Ficoll-Hypaque (Pharmacia 
Fine Chemicals Inc.,  Piscataway, N. J.).  After centrifugation, the  lymphocyte fraction was 
withdrawn and washed three times with MEM. The washed lymphocytes were then resuspended 
at a  concentration of 1  ×  106/ml  in MEM containing  10% pooled human  serum. To assay 
column fractions or eluates of polyacrylamide gel slices, 10-50 #! of the fraction was diluted 
with 1 ml of MEM-10% pooled human serum. Triplicate 100-pl samples of each dilution were 
transferred to wells of standard tissue culture microtiter plates (Falcon Labware, Div. of Becton, 
Dickinson & Co., Oxnard, Calif.) containing  100 #i of the lymphocyte preparation (100,000 
cells). The plates were incubated for 5 d  at 37°C in a  humidified atmosphere containing 5% 
CO2. After this period, 0.5 #Ci of [methyl-aH]thymidine  (6.7 Ci/mmol; New England Nuclear, 
Boston, Mass.) was added and after a  further incubation of 18 h, the cells were harvested and 
washed on  glass fiber disks using a  semi-automatic cell harvester. The disks were dried and 
radioactivity measured in a toluene-based cocktail by liquid scintillation counting. 
Enzyme Immunoassay of Streptococcal Blastogen A Antibodies.  Levels of antibodies against strep- 
tococcal blastogen A were measured using an enzyme immunoassay which was similar to that 
described by Engvall and Perlmann.  (15) Polystyrene tubes (12  ×  75 ram) (Falcon Labware) 
were coated with homogeneous blastogen A by incubating at 37°C for 60 min with 1 ml of the 
protein (10 ng/ml) dissolved in 0.1  M  Na2CO3 (pH 9.6). The tubes were stored overnight at 
4°C  then  washed  three  times with  0.9%  NaCI, 0.05%  Tween-20.  Serum  to  be assayed was 
diluted in phosphate-buffered saline (PBS) 0.05%  Tween-20, 0.02%  NAN3, and  1 ml of a series 
of dilutions (1/100,  1/300,  1/900,  1/2,700) were incubated in the coated tubes at 37°C for 30 
rain. The  tubes were washed  as before and  then  incubated with  1 ml  of goat  anti-human 
gamma chain globulin-horse radish peroxidase conjugate. Conjugate was prepared (16)  from 
the  IgG  fraction  of goat  anti-human  gamma  chain  sera  (N.  L.  Cappel  Laboratories Inc., 
Cochranville, Pa.) and horse radish peroxidase, type VI (Sigma Chemical Co., St. Louis, Mo.). 
After washing as before, 1 ml of peroxidase substrate (0.04% orthophenylenediamine, 0.006% 
H202 in citrate-phosphate buffer, pH 5.0)  (16) was incubated in the tubes at room temperature 
for 30 min when 0.5 ml of 2 M  H2SO4 was added to stop the reaction. The absorbance at 493 
nm of the colored product was measured by spectrophotometry. Control tubes not coated with 
antigen were treated identically with each serum dilution and the A493 values were subtracted. 
In  sera  with  low  antibody  levels these  control  values  represented  a  large  fraction  of the 
ahsorbance observed with antigen-coated tubes and therefore were critical for the determination 
~Abbreviations used in thzs paper: MEM,  Eagles'  minimal essential  medium;  PBS, phosphate-buffered 
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FIG.  1.  DEAE claromatography of extracellular products  from  streptococcal  strain  C203S.  The 
extracellular products were concentrated by ammonium sulfate precipitation and chromatographed 
on a  DEAE-cellulose column as described in  Materials and  Methods. I,  absorbance at  280 nm; 
A, blastogenic activity (cpm/100,000  cells); 0, nuelease activity (A260 nm/10 min). 
of meaningful  titers. The corrected A4aa values were plotted against  the serum  dilutions on a 
log/log scale. The antibody titer was arbitrarily set at that extrapolated serum dilution which 
would produce an A493 of 0.100. 
Anti-DNase B levels were determined by the microtiter technique of Nelson et al. (17). 
Enzyme Treatment of Streptococcal Blastogen A.  A  sample  of a  homogeneous  preparation  of 
blastogen A  (1/xg/mi) was incubated separately with 100 #g pancreatic RNase, 100 #g pronase, 
and  I00 btg trypsin (all from Sigma Chemical Co.) for 60 min at 37°C. The samples, including 
a  control incubated  without enzyme, were heated at  100°C for  10 min to inactivate enzymes 
and then the residual activity was assayed for blastogenic activity. 
Results 
Purification of Streptococcal Blastogen A.  The extracellular products of strain C203S 
contained  a  single  major peak of blastogenic  activity  when fractionated  on DEAE- 
cellulose  (Fig.  1). The blastogenic  activity  overlapped  streptococcal  nuclease A  and 
was completely  separated  from  the  earlier eluting  nucleases  B  and  D,  which  were 
assayed  as reference markers. The blastogen peak was pooled and chromatographed 
on CM-cellulose  at pH 5  (Fig.  2).  This procedure separated  the blastogen  from the 
bulk of other protein as well as from nuclease A. In most preparations, the blastogenic 
activity,  hereafter  referred to as streptococcal  blastogen  A,  was  homogeneous  after 
CM chromatography  (Fig. 3). An occasional contamination with nuclease A could be 
removed by rechromatography  on CM-cellulose.  The single band of protein on SDS 
polyacrylamide gel electrophoresis had a mobility characteristic of a mol wt of 17,500 
(Fig. 3). 4.0 
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FIG. 2.  CM-cellulose chromatography ofblastogenic activity from DEAE-cellulose column eluate. 
II, A28o nm; A, blastogenic activity (cpm/100,000  cells); O, nuclease  activity (A260 nm/10 min). 
Effect  of Enzymes  on  Streptococcal Blastogen  A.  The  nature  of  blastogen  A  was 
examined by digestion with various enzymes. The activity is unaffected by pancreatic 
RNase but is destroyed by pronase and trypsin. The active portion of the blastogen 
is therefore likely to be a protein. 
Heat  Stability  of Streptococcal Blastogen A.  The  heat  stability of blastogen  A  was 
examined  by  measuring  the  activity remaining  after  various  times  of heating  at 
100°C.  Blastogen  A  was  rapidly  and  apparently  irreversibly  denatured  by  this 
treatment with <10% of the activity remaining after 5 min of heating. The purified 
material and the blastogenic activity in crude extracts from strain C203S were both 
affected. The  blastogenic  activity in  crude  extracellular  products  from  all  of the 
streptococcal strains listed in Table I showed kinetics of heat denaturation similar to 
the purified material from strain C203S. 
Production of Blastogenic Activity  by  Various Streptococcal Strains.  The  production  of 
extracellular  blastogenic  activity  by  several  strains  of group  A  streptococci  was 
examined in crude extracts prepared  from stationary phase cultures  (Table I). The 
levels of blastogenic activity varied from 0.1 to nearly 30 stimulation U//~g of protein 
but  all  of  the  strains  examined  produced  measurable  lymphocyte  transforming 
activity. It is possible that the blastogenic activity in some of the cultures was due to 
another streptococcal product but evidence from the enzyme immunoassay of anti- 
blastogen A-IgG suggests that the production of blastogen A is a common property of 
group A streptococci. 
Polyaqylamide  Gel Electrophoresis of Streptococcal Blastogen A.  The electrophoresis of 
homogeneous blastogen A preparations in nondenaturing polyacrylamide gels resulted 1442  STREPTOCOCCAL EXTRACELLULAR BLASTOGEN 
FIG. 3.  SDS polyacrylamide  gel of blastogen A. 
in the appearance of multiple bands of protein with a broad spectrum of electropho- 
retic  mobility  (Fig.  4a).  A  companion  gel  was  sliced  and  eluted  and  blastogenic 
activity was measured in the eluates. The peak of activity was not correspondent to 
the major protein bands that had barely detectable blastogenic activity. Instead, the 
biological activity was associated with minor protein bands of much higher mobility. 
In another experiment (data not shown) in which a similar gel was fractionated into 
thinner slices,  two separate peaks of blastogenic activity was apparent, corresponding 
to  the  two  protein  bands.  One  explanation  of  these  observations  could  be  the ERNEST  D.  GRAY 
TABLE I 
Extracellular Blastogen Activity from Culture Supernates of Various Strains of 
Group A Streptococci 
Stimulation  Strain  Source  M type  T type  units* 
per ttg protein 
GT-71-675  Univ. of Minn.  M 1  T1  29.6 
GT-71-676  Univ. of Minn.  M2  T2  3.4 
GT-71-677  Univ. of Minn.  M3  T3  0.8 
GT-75-194  Univ, of Minn.  M4  T4  0.2 
GT-71-681  Univ. of Minn.  M6  T6  0.1 
C203S  A. Bernheimer  M3  T 1  27.1 
* Stimulation  unit was calculated as follows: (cpm of dilution of blastogen/ 
cpm of maximum stimulation)  ×  dilution factor  =  stimulation  units (in 
undiluted  blastogen preparation). The value reported is from a dilution on 
the linearly decreasing portion of the titration curve (see Fig. 6). 
1443 
formation of oligomeric forms of blastogen A  through disulfide cross linkage.  In fact, 
the treatment of the blastogen A preparation with dithiothreitol before electrophoresis 
(Fig. 4 b) resulted in a marked reduction in the major protein bands and the generation 
of a  previously absent  protein  species coincident  with  the blastogenic  activity.  This 
latter  protein  is of greater mobility than  either of the two active species in the non- 
reduced  blastogen  A  gel.  If dithiothreitol  treatment  is  prolonged,  all  of the  slower 
migrating proteins  are absent  with  the single band of protein  remaining coincident 
with the blastogenic activity. 
Relationship  of  Streptococcal  Pyrogenic Exotoxins  to  Blastogen  A.  The  streptococcal 
pyrogenic exotoxins are mitogens produced by many strains of group A  streptococci. 
To compare blastogen A  with these entities,  the electrophoretic  mobilities of strepto- 
coccal pyrogenic exotoxins  A,  B,  and  C  and  that  of blastogen  A  in  polyacrylamide 
gels were determined (Table II). Exotoxins A and C are obviously different in mobility 
from blastogen A, which has a  mobility in the range of that of exotoxin B; this latter 
protein was present  as two-charge isomers. 
To further examine the possibility that  blastogen A  was identical  with one of the 
streptococcal pyrogenic exotoxins, specific rabbit antisera were used in the lymphocyte 
stimulation  assay. The blastogenic response to various concentrations of blastogen A 
was measured  in the  presence of antisera  to the  pyrogenic exotoxins.  The results  of 
such  an  experiment  (Fig.  5)  indicate  that  none  of the  antisera,  with  the  possible 
exception of anti-exotoxin A, significantly affected the stimulation of lymphocytes by 
blastogen A, suggesting that the pyrogenic exotoxins are dissimilar antigenically from 
blastogen A. 
A  possibility existed that these antisera, even if directed toward blastogen A, could 
not inhibit  the lymphocyte response.  In a  separate experiment,  human serum shown 
to contain  anti-blastogen  A-IgG by enzyme immunoassay was incubated  with  lym- 
phocytes and varying concentrations of blastogen A  (Fig. 6).  As the results  indicate, 
the  lymphocyte transformation  response  to blastogen  A  was  markedly  inhibited  in 
the presence of the anti-blastogen A serum. It would appear that inability of the anti- 
pyrogenic exotoxin  sera  to inhibit  the  lymphocyte response  to blastogen  A  (Fig.  5) 
reflects antigenic differences between blastogen A  and the exotoxins. 1444  STREPTOCOCCAL  EXTRACELLULAR  BLASTOGEN 
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FIo.  4.  Electrophoresis of streptococcal blastogen A in nondenaturing polyacrylamide gels. (a) A 
homogeneous preparation of blastogen A was electrophoresed in polyacrylamide gels as described 
in Materials and Methods. One gel was stained for protein and a companion gel was sliced with a 
template into equal slices -~3 mm thick. The slices were eluted with 1.0 ml of 0.001  M Tris(pH 7), 
0.001  M  MgCI~, 0.001  M  CaCI~ overnight at 4°C and the blastogenic activity was assayed in the 
eluates. (b) The same blastogen A preparation was made 0.01 M with respect to dithiothreitol and 
incubated at  37°C  for  t  h  before electrophoresis as  in  (a).  6,  cpm/100,000  cells;  --,  A:,9.~ nm 
(protein). 
Antibodies  to Streptococcal Blastogen A  m Human Sera.  The  humoral  immunogenicity 
of blastogen  A  was  examined  by  means  of an  enzyme  immunoassay  for  antibodies 
directed  against  this  antigen  m  h.uman  sera.  The  results  of a  survey  of sera  with  a 
range  of  antibody  titers  against  streptococcal  DNase  B  are  shown  in  Table  III. 
Antibodies  to blastogen A  appear  to be present  in sera in which  anti-DNase  B  levels 
are elevated. The  relative levels of anti-blastogen A, with some exceptions, correspond 
to those of anti-DNase  B. In certain sera, the anti-blastogen  A  level was undetectable 
although  low  levels  of anti-DNase  B  were  present.  In  this  small  group  of sera,  the ERNEST  D.  GRAY  1445 
TABLE II 
Comparison of Electrophoretic Mobility of Blastogen A with Streptococcal 
Pyrogenic Exotoxins 
Rm 
Streptococcal blastogen A  0.75, 0.84 
Streptococcal pyrogenic exotoxin  A  0.27 
B  0.64, 0.68 
C  0.39 
The purified materials were electrophoresed on 7.5% polyacrylamide gels as in 
Materials and Methods. The mobilities of the proteins are relative to that of 
bromophenol blue. 
infecting strains  of streptococci  were  not  available;  however,  it  seems  likely that 
blastogen A is a common antigen produced by a variety of streptococci. 
Discussion 
The present study has demonstrated the isolation in homogeneous form of a group 
A streptococcal extracellular product capable of stimulating lymphocyte blastogenesis. 
The  protein,  termed  streptococcal  blastogen  A,  has  a  mol  wt  of  17,500  and  is 
susceptible to heat denaturation and readily forms disulfide cross-linked species, most 
of which are relatively inactive on lymphocytes. 
A variety of streptococcal cellular, cell-bound, and extracellular proteins have the 
ability to induce lymphocyte  blastogenesis. Abe and Alouf (6) have partially purified 
an extracellular blastogenic substance which appeared to have a mol wt of 50,000 as 
estimated by gel filtration and an isoelectric point near 4.7. This substance corresponds 
in size to a  glycopeptide mitogen extracted from resting streptococci by Plate and 
Amos (4, 5). Seravalli and Taranta (1) have described an extracellular mitogen from 
the  same  group  A  streptococcal  strain  (C203S)  that  was  the  principal  source  of 
material used in the present study. In this case, the mitogenic substance appeared to 
be heterogeneous, with a  major species of mol wt 26,000  and an isoelectric point of 
6.9.  However, in the present study the DEAE chromatograms of crude extracellular 
products from two distinct group A strains (C203S and $43)  show the same pattern 
of blastogenic activity, a  single major peak with little evidence for other blastogens. 
If indeed the mitogens described by Seravalli and Taranta (1)  are separate species, 
they are not detectable by the fractionation techniques used to purify blastogen A. A 
possible explanation for the heterogeneity reported by these authors could be related 
to the observations of multiple disulfide linked forms on polyacrylamide gel electro- 
phoresis (Fig. 4). 
Another group of mitogenic proteins that are produced by group A streptococci are 
the streptococcal pyrogenic exotoxins (SPE), also known as the streptococcal erythro- 
genic toxins (7-9). Three distinct species of SPE exist with mol wt of 8,000,  17,500, 
and 13,000, respectively, for SPE A, B, and C. The molecular weight and electropho- 
retic mobility of SPE A  and C  are clearly different from blastogen A. Exotoxin B, 
however, is similar in mobility to blastogen A and has an identical molecular weight. 
Furthermore, exotoxin B exists as two charge isomers and two active forms ofblastogen 
A are separable by gel electrophoresis. Nauciel et al. (18) have reported that erythro- 
genic toxin (SPE-A) can be isolated in two distinct forms which are convertible to a 1446  STREPTOCOCCAL  EXTRACELLULAR  BLASTOGEN 
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FIG.  5.  Effect of antisera to streptococcal pyrogenic exotoxins A, B, and C  on the stimulation of 
lymphocyte blastogenesis by streptococcal blastogen A. Lymphocyte stimulation by varying concen- 
trations of blastogen A  was measured as described  in  Methods in  the presence of specific rabbit 
antisera to either SPE A, B, or C  diluted  1:100.  The control curve was an assay performed without 
rabbit sera. O, control; A, anti-SPE A; m, anti-SPE B; Fq, anti-SPE C. 
single species by reduction. Similar behavior was observed with blastogen A  in the 
present investigation, although multiple inactive and two active forms of blastogen A 
were  converted to  a  single  active species.  This  property appears  to  be  shared  by 
streptococcal nuclease B, which exists in multiple forms (19), some of which are absent 
after reduction with dithiothreitol (Gray, E. D. Unpublished results). It may, therefore, 
be a more general property of streptococcal extracellular products. 
The lack of significant inhibition of lymphocyte stimulation by blastogen A in the 
presence of antisera to the streptococcal pyrogenic exotoxins appears to indicate that 
blastogen A is antigenically dissimilar to these entities. An alternative interpretation 
of these results is that  the antigenic sites which specify the humoral antibodies are 
different from those involved in the lymphocyte blastogenic response. This appears to 
be the case with some systems (20) and under these circumstances, even if blastogen 
A was identical to one of the pyrogenic exotoxins, the antibodies against  the toxins 
might not be directed at the antigenic site which interacts with lymphocytes. However, 
a  recent  study  indicates  that  the  mitogenic  activity  of erythrogenic toxin  can  be 
inhibited by specific rabbit antisera to the toxin  (91).  Furthermore, the blastogenic 
activity of blastogen  A  was  inhibited  by serum  containing antibodies  against  this 
protein (Fig. 6). It appears that blastogen A is not closely antigenically related to the 
pyrogenic exotoxins. Further studies will be required to exclude the possibility that 
blastogen A may be identical with or related to one of the other known extracellular 
products of group A streptococci. 
The lymphocyte stimulating  substances  isolated  from streptococcal extracellular 
products have been termed mitogens, because they induce blastogenesis in lympho- 
cytes from animals presumably unsensitized by streptococcal antigens  (1,  2).  In the 
absence  thus  far  of definitive evidence,  the  stimulating  substance  purified  in  the 
present  investigation  has  been  termed  a  blastogen.  The  detection of antibodies  to ERNEST  D.  GRAY  1447 
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Flo.  6.  Effect of human  antiserum  to  streptococcal blastogen  A  on  lymphocyte blastogenesis. 
Lymphocyte stimulation by varying concentrations of blastogen A was measured in the presence of 
10% human serum containing anti-blastogen A-IgG (titer of 2,500).  The control was a similar assay 
performed with the usual  10% pooled human sera. dk, control; O, anti-blastogen A. 
blastogen A  in human sera and their inhibition of lymphocyte stimulation suggest 
that the human response to blastogen A is by lymphocytes sensitized to the antigen. 
The  possibility exists  that  blastogen  A  is  also  a  nonspecific mitogen,  stimulating 
unsensitized lymphocytes, and this will be a subject for future studies on lymphocytes 
from human cord blood. 
Streptococcal blastogen A is evidently produced by a  wide variety of streptococci 
as evidence by the presence of antibodies to this protein in a small, randomly selected 
group of human sera. Furthermore, blastogenic activity has been directly detected in 
several group A strains (Table I). Although this activity could be due to a variety of 
streptococcal  products,  it has similar chromatographic properties  in  two unrelated 
strains. If, indeed, blastogen A is a common streptococcal extracellular product, most 
adults will have been exposed to this antigen. The blastogenic response to blastogen 
A  will,  therefore,  represent  an  index  of the  reactivity of an  individual's immune 
system to a streptococcal antigen. A survey of such responses may allow the demon- 
stration of altered reactivity in individuals with clinical evidence of post-streptococcal 
disease  (acute  nephritis,  acute rheumatic  fever, and  rheumatic heart  disease)  and 
perhaps  allow  the  identific~ion of those  at  risk  for  these  diseases.  Such  a  study 
employing the purified blastogen A is presently underway. 
Summary 
An extracellular product of group A streptococci which induces lymphocyte blas- 
togenesis  has  been  purified  to  homogeneity by  DEAE-ce'llulose and  CM-cellulose 
chromatography. The protein, termed streptococcal blastogen A, has a  mol wt of 
17,500  and  is  inactivated  by  protease  treatment  and  by  heating  at  100°C.  The 
purified blastogen gave rise to multiple protein bands on nondenaturing polyacryl- 
amide gel electrophoresis, only two of which possessed blastogenic activity. Treatment 
of the  protein  with  dithiothreitol  before  electrophoresis  resulted  in  the  apparent 1448  STREPTOCOCCAL  EXTRACELLULAR  BLASTOGEN 
TABLE III 
Comparison of Levels of Antibody  to DNase B  and Blastogen  A 
Serum No. 
Antibody titer 
Anti-DNase B  Anti-blastogen A 
9793  <50  0 
9788  240  0 
9761  32O  0 
9747  480  265 
9810  20O  465 
9743  480  1130 
9765  800  1400 
9746  800  2125 
A group of human sera selected for differing levels  ofanti-DNase B was assayed 
for anti-blastogen A levels by an enzyme immunoassay as described in Mate- 
rials and Methods. 
conversion of the  multiple forms  to  a  single active species.  Blastogen  A  differs  in 
electrophoretic mobility from the streptococcal pyrogenic exotoxins and its lympho- 
cyte  stimulating activity  is  not  inhibited by  rabbit  antisera  to  the  exotoxins.  An 
enzyme  immunoassay has  been  developed  to  measure  human  antibodies  against 
blastogen A. A  selection of sera with varying levels of anti-DNase B contained anti- 
blastogen A-IgG. 
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